377 related articles for article (PubMed ID: 17340027)
21. Nail psoriasis: treatment with tazarotene 0.1% hydrophilic ointment.
Fischer-Levancini C; Sánchez-Regaña M; Llambí F; Collgros H; Expósito-Serrano V; Umbert-Millet P
Actas Dermosifiliogr; 2012 Oct; 103(8):725-8. PubMed ID: 22818395
[TBL] [Abstract][Full Text] [Related]
22. Treating Psoriasis With Halobetasol Propionate and Tazarotene Combination: A Review of Phase II and III Clinical Trials.
Ramachandran V; Bertus B; Bashyam AM; Feldman SR
Ann Pharmacother; 2020 Sep; 54(9):872-878. PubMed ID: 32126800
[No Abstract] [Full Text] [Related]
23. Medication formulation affects quality of life: a randomized single-blind study of clobetasol propionate foam 0.05% compared with a combined program of clobetasol cream 0.05% and solution 0.05% for the treatment of psoriasis.
Bergstrom KG; Arambula K; Kimball AB
Cutis; 2003 Nov; 72(5):407-11. PubMed ID: 14655784
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of pulsed dye laser plus topical tazarotene versus topical tazarotene alone in psoriatic nail disease: a single-blind, intrapatient left-to-right controlled study.
Huang YC; Chou CL; Chiang YY
Lasers Surg Med; 2013 Feb; 45(2):102-7. PubMed ID: 23423871
[TBL] [Abstract][Full Text] [Related]
25. Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized, parallel-group study.
Lowe N; Gifford M; Tanghetti E; Poulin Y; Goldman M; Tse Y; Yamauchi P; Rosenzweig H; Kang S
J Cosmet Laser Ther; 2004 Jun; 6(2):79-85. PubMed ID: 15203997
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of acitretin and topical clobetasol in trachyonychia involving all twenty nails.
Kolbach-Rengifo M; Navajas-Galimany L; Araneda-Castiglioni D; Reyes-Vivanco C
Indian J Dermatol Venereol Leprol; 2016; 82(6):732-734. PubMed ID: 27643549
[No Abstract] [Full Text] [Related]
27. Efficacy and safety study of tazarotene cream 0.1% for the treatment of brittle nail syndrome.
Sherber NS; Hoch AM; Coppola CA; Carter EL; Chang HL; Barsanti FR; Mackay-Wiggan JM
Cutis; 2011 Feb; 87(2):96-103. PubMed ID: 21416778
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of tazarotene and acitretin in psoriasis.
Heath MS; Sahni DR; Curry ZA; Feldman SR
Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):919-927. PubMed ID: 30134735
[TBL] [Abstract][Full Text] [Related]
29. Childhood nail psoriasis: a useful treatment with tazarotene 0.05%.
Diluvio L; Campione E; Paternò EJ; Mordenti C; El Hachem M; Chimenti S
Pediatr Dermatol; 2007; 24(3):332-3. PubMed ID: 17542899
[TBL] [Abstract][Full Text] [Related]
30. Safety and efficacy of a fixed combination of halobetasol and tazarotene in the treatment of moderate-to-severe plaque psoriasis: Results of 2 phase 3 randomized controlled trials.
Gold LS; Lebwohl MG; Sugarman JL; Pariser DM; Lin T; Martin G; Pillai R; Israel R; Ramakrishna T
J Am Acad Dermatol; 2018 Aug; 79(2):287-293. PubMed ID: 29614243
[TBL] [Abstract][Full Text] [Related]
31. Short contact therapy with tazarotene in psoriasis vulgaris.
Veraldi S; Caputo R; Pacifico A; Peris K; Soda R; Chimenti S
Dermatology; 2006; 212(3):235-7. PubMed ID: 16549919
[TBL] [Abstract][Full Text] [Related]
32. A randomized, investigator-masked clinical evaluation of the efficacy and safety of clobetasol propionate 0.05% shampoo and tar blend 1% shampoo in the treatment of moderate to severe scalp psoriasis.
Griffiths CE; Finlay AY; Fleming CJ; Barker JN; Mizzi F; Arsonnaud S
J Dermatolog Treat; 2006; 17(2):90-5. PubMed ID: 16766333
[TBL] [Abstract][Full Text] [Related]
33. Tazarotene 0.1% cream for the treatment of photodamage.
Phillips TJ
Skin Therapy Lett; 2004 Apr; 9(4):1-2. PubMed ID: 15146262
[TBL] [Abstract][Full Text] [Related]
34. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
[TBL] [Abstract][Full Text] [Related]
35. DUOBRII™ (Halobetasol Propionate and Tazarotene) Lotion for Topical Use: A Newly Approved Combination Corticosteroid and Retinoid Topical Treatment of Plaque Psoriasis in Adults.
Gupta AK; Love RP; Abramovits W; Vincent KD
Skinmed; 2019; 17(3):181-183. PubMed ID: 31496472
[No Abstract] [Full Text] [Related]
36. In vitro compatibility of tazarotene with other topical treatments of psoriasis.
Hecker D; Worsley J; Yueh G; Lebwohl M
J Am Acad Dermatol; 2000 Jun; 42(6):1008-11. PubMed ID: 10827404
[TBL] [Abstract][Full Text] [Related]
37. [Assessment of value and risks of external treatment with clobetasol-17-propionate (Dermovate)].
van der Harst LC; Smeenk G; Burger PM; van der Rhee HJ; Polano MK
Ned Tijdschr Geneeskd; 1978 Feb; 122(7):219-23. PubMed ID: 345134
[No Abstract] [Full Text] [Related]
38. A multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage.
Kang S; Krueger GG; Tanghetti EA; Lew-Kaya D; Sefton J; Walker PS; Gibson JR;
J Am Acad Dermatol; 2005 Feb; 52(2):268-74. PubMed ID: 15692472
[TBL] [Abstract][Full Text] [Related]
39. [Topical treatments for psoriasis in 2009].
Thielen AM; Laffitte E
Rev Med Suisse; 2009 Apr; 5(200):876, 878-81. PubMed ID: 19438087
[TBL] [Abstract][Full Text] [Related]
40. Clobetasol propionate shampoo 0.05%: a new option to treat patients with moderate to severe scalp psoriasis.
Jarratt M; Breneman D; Gottlieb AB; Poulin Y; Liu Y; Foley V
J Drugs Dermatol; 2004; 3(4):367-73. PubMed ID: 15303780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
